Residual disease post neoadjuvant chemo-immunotherapy in early triple-negative breast cancer: does it help tailor adjuvant treatment?
E Agostinetto
,
L Buisseret
,
R Salgado
,
M Kok
,
M Ignatiadis
More about this publication
Annals of oncology : official journal of the European Society for Medical Oncology
Volume
35
Issue nr.
5
Pages
409-411
Publication date
01-05-2024
Full text links
Publisher website (DOI)
10.1016/j.annonc.2024.03.003
Europe PubMed Central
38484973
Pubmed
38484973